John G. Melo is an accomplished entrepreneur, CEO, and board director with over 30 years of global synthetic biology and energy industry experience.
Prior to TMG, John was CEO of Amyris, where he played a pivotal role in the industrialization of synthetic biology, a science that involves bioengineering organisms for industrial production. Raising over $2.5B in funding, and achieved a successful IPO with peak equity value of over $5B. Achieved revenue of over $500M annually from zero – and established a business model for monetizing molecules with over $1B in license and collaboration fees by successfully targeting and scaling 14 molecules that are currently consumed by over 400 million consumers daily and represent market share leadership in their respective end markets.
Prior to Amyris, John held various senior executive positions at BP, including most recently serving as President of US Fuels. At BP he had P&L responsibility for fuel marketing, supply chain and petroleum products business. Respected inside BP as an innovative leader with a track record for solving and troubleshooting the biggest & most complex problems inside the company. Established leader with deep knowledge of global fuel markets, global branding and large-scale transformation and M&A integration.
John is fluent in both Portuguese and English and is highly regarded as a writer and speaker. He is frequently quoted in major business publications on topics centering on industrial biotechnology, sustainability, and beauty brand building, health and wellness markets, and digital marketing.